IN THE NEWS: Zafgen Completes Enrollment of U.S. Phase 3 Trial of Beloranib in Prader-Willi Syndrome

http://pipelinereview.com/index.php/2015052857849/Small-Molecules/Zafgen-Completes-Enrollment-of-U.S.-Phase-3-Trial-of-Beloranib-in-Prader-Willi-Syndrome.html

1 thought on “IN THE NEWS: Zafgen Completes Enrollment of U.S. Phase 3 Trial of Beloranib in Prader-Willi Syndrome

Leave a reply to PapaBob Cancel reply